Prevention of stroke recurrence

International Psychogeriatrics

Volumn 15, Issue SUPPL. 1, 2003, Pages 167-171

  Gorelick, Philip B ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b Center for Stroke Research   (United States)

Author keywords

Antiplatelet agents; Carotid endarterectomy; Stroke recurrence; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; PERINDOPRIL; PYRIDOXINE; THIAZIDE DIURETIC AGENT; TICLOPIDINE; WARFARIN;

AGED; BLEEDING; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; HEADACHE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INFECTION RISK; INFLAMMATION; NEUTROPENIA; RECURRENT DISEASE; RISK FACTOR; SIDE EFFECT; STROKE; THROMBOCYTOPENIA; TRANSIENT ISCHEMIC ATTACK;

AGED; CEREBROVASCULAR ACCIDENT; DIPYRIDAMOLE; ENDARTERECTOMY, CAROTID; HUMANS; PLATELET AGGREGATION INHIBITORS; RECURRENCE; TICLOPIDINE; WARFARIN;

EID: 0141819874     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610203009141     Document Type: Conference Paper

References (16)

1. Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2001). Antithrombotic and thrombolytic therapy for ischemic stroke. Chest, 119, 300S-320S.
2. Bonita, R. (2001). Stroke prevention: A global perspective. In J. W. Norris & V. Hachinski (Eds.), Stroke prevention (pp. 259-274). New York: Oxford University Press.
3. Chalmers, J., & MacMahon, S., on behalf of the PROGRESS Management Committee. (2001). PROGRESS-Perindopril Protection Against Recurrent Stroke Study: Main results [abstract]. Journal of Hypertension, 19(Suppl. 2), S260.
4. Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., et al. (2001). Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation, 103, 163-182.
5. Gorelick, P. B. (1999a). Carotid endarterectomy: Where do we draw the line? Stroke, 30, 1745-1750.
6. Gorelick, P. B. (1999b). Can we save the brain from the ravages of midlife cardiovascular risk factors? Neurology, 52, 1114-1115.
7. Gorelick, P. B. (2000). Aspirin plus extended-release dipyridamole a new combination antiplatelet agent for secondary stroke prevention. National Stroke Association Stroke Clinical Updates, 10, 1-4.
8. Gorelick, P. B. (2001). Prevention and screening programs. In J. W. Norris & V. Hachinski (Eds.), Stroke prevention (pp. 117-136). New York: Oxford University Press.
9. Gorelick, P. B. (2002). Stroke prevention therapy beyond antithrombotics: Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. An invited review. Stroke, 33, 862-875.
10. Gorelick, P. B., Born, G. V. R., D'Agostino, R. B., Hanley, D. F., Moye, L., et al. (1999b). Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel. Stroke, 30, 1716-1721.
11. Gorelick, P. B., Erkinjuntti, T., Hofman, A., Rocca, W. A., Skoog, I., et al. (1999c). Prevention of vascular dementia. Alzheimer Disease and Associated Disorders, 13(Suppl. 3), S131-S139.
12. Gorelick, P. B., Sacco, R. L., Smith, D. B., Alberts, M., Mustone-Alexander, L., et al. (1999a). Prevention of a first stroke: A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. Journal of the American Medical Association, 281, 1112-1120.
13. Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999). Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Annals of Internal Medicine, 131, 492-501.
14. Sacco, R. L., Wolf, P. A., & Gorelick, P. B. (1999). Risk factors and their management for stroke prevention: Outlook for 1999 and beyond. Neurology, 53(Suppl. 4), S15-S24.
15. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. (1997). A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Annals of Neurology, 42, 857-865.
16. Wolf, P. A., Clagett, G. P., Easton, J. D., Goldstein, L. B., Gorelick, P. B., et al. (1999). Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke, 30, 1991-1994.